e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Phenotyping asthma: a clue for treatments?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Improvement of asthma control by a concomitant therapy with cineole
H. Worth (Fürth, Germany)
Source:
Annual Congress 2011 - Phenotyping asthma: a clue for treatments?
Session:
Phenotyping asthma: a clue for treatments?
Session type:
Oral Presentation
Number:
1876
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Worth (Fürth, Germany). Improvement of asthma control by a concomitant therapy with cineole. Eur Respir J 2011; 38: Suppl. 55, 1876
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Evidence-based treatments for severe asthma
Source: Annual Congress 2011 - PG13 ERS/ACCP jointly organised: evidence-based approach to advanced respiratory care
Year: 2011
Efficacy and safety of antibiotic treatment of stable COPD
Source: Annual Congress 2010 - Treatment of bronchial infection: beyond the exacerbations
Year: 2010
Indacaterol provides effective bronchodilation in patients with COPD regardless of concomitant ICS use
Source: Annual Congress 2010 - Bronchodilators in airways disease
Year: 2010
Knemometry assessment of short-term lower leg growth in children with asthma treated with fluticasone propionate/formoterol combination therapy
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015
Can flexible combination therapy reduce severe asthma exacerbations associated with common colds?
Source: Annual Congress 2010 - New aspects of treatment of lower respiratory tract infections
Year: 2010
Effects of atorvastatin in asthmatic patients under treatment with high dose inhaled or oral steroid
Source: Annual Congress 2010 - Novel anti-inflammatory agents for airway disease
Year: 2010
Effects of switching inhaled medication from twice a day to once a day in patients with bronchial asthma
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
Compliance with guidelines for pharmacological treatment of COPD: Real-life analyses
Source: Annual Congress 2010 - What's new in pulmonary rehabilitation and chronic care in 2010
Year: 2010
Tiotropium as add-on to inhaled corticosteroids significantly improves asthma control as reflected by the ACQ responder rate
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013
NVA237 once daily reduces the percentage of patients with exacerbations of COPD and associated hospitalizations: The GLOW1 trial
Source: Annual Congress 2011 - New treatments for airway disease
Year: 2011
Sputum eosinophilia identifies systemic corticosteroid responsiveness in acute exacerbations of COPD
Source: Annual Congress 2011 - Mechanism and monitoring of airway diseases
Year: 2011
Effect of aclidinium bromide/formoterol fumarate fixed-dose combination (FDC) on night-time and early morning symptoms in COPD
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
The use of household cleaning sprays, asthma severity and asthma control in the EGEA study
Source: Annual Congress 2010 - Indoor exposures to irritant chemicals, allergens and moulds and respiratory health of children and adults
Year: 2010
Clinical control of asthma associated with measures of airway inflammation
Source: Annual Congress 2010 - Asthma and COPD: understanding through monitoring
Year: 2010
Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening
Source: Eur Respir J 2001; 17: 1083-1088
Year: 2001
Morning and evening administration of inhaled ciclesonide is equally effective in treatment of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 304s
Year: 2002
Once-daily tiotropium Respimat add-on therapy improves lung function and asthma control in moderate symptomatic asthma, independent of baseline characteristics
Source: International Congress 2017 – Clinical points to ponder in asthma
Year: 2017
Increased levels of angiopoientin-1, angiopoientin-2 in sputum supernatant in severe refractory asthma
Source: Annual Congress 2010 - Biomarkers of asthma and COPD: recent advances
Year: 2010
Fluticasone propionate/formoterol fumarate improves asthma control and reduces exacerbations compared with fluticasone
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept